卡铂与阿糖胞苷治疗播散性恶性黑色素瘤患者的II期研究。
Phase II study of carboplatin and cytosine arabinoside in patients with disseminated malignant melanoma.
作者信息
Mulder N H, Sleijfer D T, de Vries E G, Schraffordt Koops H, Willemse P H
机构信息
Department of Internal Medicine, University Hospital Groningen, The Netherlands.
出版信息
J Cancer Res Clin Oncol. 1990;116(3):301-2. doi: 10.1007/BF01612907.
Abstract
Twenty-one patients with disseminated malignant melanoma were treated with a combination of carboplatin and cytosine arabinoside. Two complete and three partial remissions occurred. No complete cross-resistance was found with a regimen containing 5-(dimethyltriazeno)imidazole-4-carboxamide (DTIC) in two patients. It is suggested that this regimen might be studied further as a second-line treatment for patients who fail on DTIC-containing treatment.
摘要
21例播散性恶性黑色素瘤患者接受了卡铂和阿糖胞苷联合治疗。出现了2例完全缓解和3例部分缓解。在2例患者中，含5-(二甲基三氮烯)咪唑-4-甲酰胺（DTIC）的方案未发现完全交叉耐药。建议对含DTIC治疗失败的患者，将该方案作为二线治疗进行进一步研究。
相似文献
1
Phase II study of carboplatin and cytosine arabinoside in patients with disseminated malignant melanoma.卡铂与阿糖胞苷治疗播散性恶性黑色素瘤患者的II期研究。
J Cancer Res Clin Oncol. 1990;116(3):301-2. doi: 10.1007/BF01612907.
2
The use of irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer: systematic review and economic evaluation.伊立替康、奥沙利铂和雷替曲塞用于治疗晚期结直肠癌：系统评价与经济学评估
Health Technol Assess. 2008 May;12(15):iii-ix, xi-162. doi: 10.3310/hta12150.
3
A systematic overview of chemotherapy effects in ovarian cancer.卵巢癌化疗效果的系统综述。
Acta Oncol. 2001;40(2-3):340-60. doi: 10.1080/02841860151116420.
4
Platinum-containing regimens for metastatic breast cancer.转移性乳腺癌的含铂方案。
Cochrane Database Syst Rev. 2017 Jun 23;6(6):CD003374. doi: 10.1002/14651858.CD003374.pub4.
5
Phase II study of bleomycin, dacarbazine (DTIC) and vindesine in disseminated malignant melanoma.博来霉素、达卡巴嗪（DTIC）和长春地辛治疗播散性恶性黑色素瘤的II期研究。
J Cancer Res Clin Oncol. 1989;115(1):93-5. doi: 10.1007/BF00391607.
6
Comparison of first-line chemotherapy including escalated BEACOPP versus chemotherapy including ABVD for people with early unfavourable or advanced stage Hodgkin lymphoma.对早期预后不良或晚期霍奇金淋巴瘤患者，比较包括强化BEACOPP方案的一线化疗与包括ABVD方案的化疗。
Cochrane Database Syst Rev. 2017 May 25;5(5):CD007941. doi: 10.1002/14651858.CD007941.pub3.
7
Combined programmed cell death protein 1 and cytotoxic T-lymphocyte associated protein 4 blockade in an international cohort of patients with acral lentiginous melanoma.肢端雀斑样痣黑色素瘤国际患者队列中程序性细胞死亡蛋白1与细胞毒性T淋巴细胞相关蛋白4联合阻断治疗
Br J Dermatol. 2025 Jan 24;192(2):316-326. doi: 10.1093/bjd/ljae401.
8
Carboplatinum and cytosine arabinoside in patients with disseminated malignant melanoma. A phase II study.卡铂和阿糖胞苷用于播散性恶性黑色素瘤患者：一项II期研究。
Invest New Drugs. 1991 Aug;9(3):277-80. doi: 10.1007/BF00176984.
9
Intermittent interferon and polychemotherapy in metastatic melanoma.转移性黑色素瘤的间歇性干扰素与多药化疗
J Cancer Res Clin Oncol. 1995;121(3):175-80. doi: 10.1007/BF01198100.
10
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
引用本文的文献
1
Vinblastin-carboplatin for metastatic cutaneous melanoma as first-line chemotherapy and in dacarbazine failures: a single-center study.长春碱-卡铂用于转移性皮肤黑色素瘤的一线化疗及达卡巴嗪治疗失败后的情况：一项单中心研究
Med Oncol. 2001;18(3):189-95. doi: 10.1385/MO:18:3:189.
2
Phase II study of second-line therapy with DTIC, BCNU, cisplatin and tamoxifen (Dartmouth regimen) chemotherapy in patients with malignant melanoma previously treated with dacarbazine.达卡巴嗪治疗过的恶性黑色素瘤患者采用达卡巴嗪、卡莫司汀、顺铂和他莫昔芬（达特茅斯方案）进行二线化疗的II期研究。
Br J Cancer. 2000 Jun;82(11):1759-63. doi: 10.1054/bjoc.2000.1141.
3
Carboplatinum and cytosine arabinoside in patients with disseminated malignant melanoma. A phase II study.卡铂和阿糖胞苷用于播散性恶性黑色素瘤患者：一项II期研究。
Invest New Drugs. 1991 Aug;9(3):277-80. doi: 10.1007/BF00176984.
本文引用的文献
1
Synergistic lethal effect of cis-dichlorodiammineplatinum and 1-beta-D-arabinofuranosylcytosine.顺式二氯二氨铂与1-β-D-阿拉伯呋喃糖基胞嘧啶的协同致死效应。
Cancer Res. 1981 Jan;41(1):25-30.
2
Chemotherapy of malignant melanoma.恶性黑色素瘤的化疗
Cancer. 1972 Dec;30(6):1604-15. doi: 10.1002/1097-0142(197212)30:6<1604::aid-cncr2820300629>3.0.co;2-5.
3
Lack of synergy between cisplatin and cytarabine against ovarian carcinoma in vitro.
Cancer Treat Rep. 1986 Mar;70(3):409-10.
4
Cytarabine and cisplatin in advanced malignant melanoma.阿糖胞苷和顺铂用于晚期恶性黑色素瘤
Cancer Treat Rep. 1986 Dec;70(12):1441-2.
5
Phase II trial of carboplatin in advanced malignant melanoma.卡铂用于晚期恶性黑色素瘤的II期试验。
Cancer Treat Rep. 1987 Feb;71(2):171-2.
6
7
WR-2721 and high-dose cisplatin: an active combination in the treatment of metastatic melanoma.
J Clin Oncol. 1987 Apr;5(4):574-8. doi: 10.1200/JCO.1987.5.4.574.
8
Phase II study of bleomycin, dacarbazine (DTIC) and vindesine in disseminated malignant melanoma.博来霉素、达卡巴嗪（DTIC）和长春地辛治疗播散性恶性黑色素瘤的II期研究。
J Cancer Res Clin Oncol. 1989;115(1):93-5. doi: 10.1007/BF00391607.
9
"Platinum-pyrimidine blues" and related complexes: a new class of potent antitumor agents.
Cancer Chemother Rep. 1975 Mar-Apr;59(2 Pt 1):287-300.
10
Pharmacokinetics of cytosine arabinoside in acute myeloid leukemia.
Clin Pharmacol Ther. 1977 Jun;21(6):744-50. doi: 10.1002/cpt1977216744.
Zotero 插件